C. Ferri, M. Prince, and C. Brayne, Global prevalence of dementia: a Delphi consensus study, The Lancet, vol.366, issue.9503, pp.2112-2129, 2005.
DOI : 10.1016/S0140-6736(05)67889-0

D. Barnes and K. Yaffe, The projected effect of risk factor reduction on Alzheimer's disease prevalence, The Lancet Neurology, vol.10, issue.9, pp.819-847
DOI : 10.1016/S1474-4422(11)70072-2

K. Ritchie, I. Carriere, and C. Ritchie, Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors, BMJ, vol.341, issue.aug05 2, p.3885
DOI : 10.1136/bmj.c3885

URL : https://hal.archives-ouvertes.fr/inserm-00520527

P. Alexopoulos, T. Richter-schmidinger, and M. Horn, Hippocampal volume differences between healthy young apolipoprotein E epsilon2 and epsilon4 carriers, J Alzheimers Dis, vol.26, pp.207-217

C. Hulette, K. Welsh-bohmer, and M. Murray, Neuropathological and Neuropsychological Changes in ???Normal??? Aging, Journal of Neuropathology and Experimental Neurology, vol.57, issue.12, pp.1168-74, 1998.
DOI : 10.1097/00005072-199812000-00009

J. Morris and J. Price, Pathologic Correlates of Nondemented Aging, Mild Cognitive Impairment, and Early-Stage Alzheimer's Disease, Journal of Molecular Neuroscience, vol.17, issue.2, pp.101-119, 2001.
DOI : 10.1385/JMN:17:2:101

F. Song, A. Poljak, and M. Valenzuela, Meta-analysis of plasma amyloid-beta levels in Alzheimer's disease, J Alzheimers Dis, vol.26, pp.365-75

A. Fagan, M. Mintun, and R. Mach, in humans, Annals of Neurology, vol.111, issue.3, pp.512-531, 2006.
DOI : 10.1002/ana.20730

D. Selkoe, Defining Molecular Targets to Prevent Alzheimer Disease, Archives of Neurology, vol.62, issue.2, pp.192-197, 2005.
DOI : 10.1001/archneur.62.2.192

L. Shaw, H. Vanderstichele, and M. Knapik-czajka, Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects, Annals of Neurology, vol.55, issue.4, pp.403-416, 2009.
DOI : 10.1002/ana.21610

A. Fagan, C. Roe, and C. Xiong, Cerebrospinal Fluid tau/??-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults, Archives of Neurology, vol.64, issue.3, pp.343-352, 2007.
DOI : 10.1001/archneur.64.3.noc60123

R. Sperling, P. Aisen, and L. Beckett, Toward defining the preclinical stages of Alzheimer???s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's & Dementia, vol.7, issue.3, pp.280-92
DOI : 10.1016/j.jalz.2011.03.003

C. Jack, . Jr, V. Lowe, and M. Senjem, 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment, Brain, vol.131, issue.3, pp.665-80, 2008.
DOI : 10.1093/brain/awm336

O. Hansson, H. Zetterberg, and P. Buchhave, Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study, The Lancet Neurology, vol.5, issue.3, pp.228-262, 2006.
DOI : 10.1016/S1474-4422(06)70355-6

G. Li, I. Sokal, and J. Quinn, CSF tau/A??42 ratio for increased risk of mild cognitive impairment: A follow-up study, Neurology, vol.69, issue.7, pp.631-640, 2007.
DOI : 10.1212/01.wnl.0000267428.62582.aa

R. Petersen, P. Aisen, and L. Beckett, Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization, Neurology, vol.74, issue.3, pp.201-210
DOI : 10.1212/WNL.0b013e3181cb3e25

M. Ferretti and A. Cuello, Does a Pro-Inflammatory Process Precede Alzheimer's Disease and Mild Cognitive Impairment?, Current Alzheimer Research, vol.999, issue.999, pp.164-74
DOI : 10.2174/1567211213451702050

F. Strang, A. Scheichl, and Y. Chen, Amyloid Plaques Dissociate Pentameric to Monomeric C-Reactive Protein: A Novel Pathomechanism Driving Cortical Inflammation in Alzheimer's Disease?, Brain Pathology, vol.12, issue.6738, pp.337-383
DOI : 10.1111/j.1750-3639.2011.00539.x

H. Abildstrom, L. Rasmussen, and P. Rentowl, Cognitive dysfunction 1-2 years after non-cardiac surgery in the elderly, Acta Anaesthesiologica Scandinavica, vol.96, issue.Suppl. 172, pp.1246-51, 2000.
DOI : 10.1034/j.1399-6576.2000.441010.x

N. Fox, E. Warrington, and M. Rossor, Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease, The Lancet, vol.353, issue.9170, p.2125, 1999.
DOI : 10.1016/S0140-6736(99)00496-1

D. Devanand, G. Pradhaban, and X. Liu, Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease, Neurology, vol.68, issue.11, pp.828-864, 2007.
DOI : 10.1212/01.wnl.0000256697.20968.d7

N. Carlson, M. Moore, and A. Dame, Trajectories of brain loss in aging and the development of cognitive impairment, Neurology, vol.70, issue.11, pp.828-861, 2008.
DOI : 10.1212/01.wnl.0000280577.43413.d9

R. Killiany, B. Hyman, and T. Gomez-isla, MRI measures of entorhinal cortex vs hippocampus in preclinical AD, Neurology, vol.58, issue.8, pp.1188-96, 2002.
DOI : 10.1212/WNL.58.8.1188

R. Scahill, J. Schott, and J. Stevens, Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI, Proceedings of the National Academy of Sciences, vol.99, issue.7, pp.4703-4710, 2002.
DOI : 10.1073/pnas.052587399

J. Schott, N. Fox, and C. Frost, Assessing the onset of structural change in familial Alzheimer's disease, Annals of Neurology, vol.55, issue.2, pp.181-189, 2003.
DOI : 10.1002/ana.10424

K. Kantarci, C. Jack, and . Jr, Neuroimaging in Alzheimer disease: an evidence-based review, Neuroimaging Clinics of North America, vol.13, issue.2, pp.197-209, 2003.
DOI : 10.1016/S1052-5149(03)00025-X

G. Mckhann, D. Knopman, and H. Chertkow, The diagnosis of dementia due to Alzheimer???s disease: Recommendations from the National Institute on Aging-Alzheimer???s Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's & Dementia, vol.7, issue.3, pp.263-272
DOI : 10.1016/j.jalz.2011.03.005

E. Burton, R. Barber, and E. Mukaetova-ladinska, Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis, Brain, vol.132, issue.1, pp.195-203, 2009.
DOI : 10.1093/brain/awn298

O. Brien, J. Lloyd, A. Mckeith, and I. , A Longitudinal Study of Hippocampal Volume, Cortisol Levels, and Cognition in Older Depressed Subjects, American Journal of Psychiatry, vol.161, issue.11, pp.2081-90, 2004.
DOI : 10.1176/appi.ajp.161.11.2081

A. Singh-manoux, M. Kivimaki, and M. Glymour, Timing of onset of cognitive decline: results from Whitehall II prospective cohort study, BMJ, vol.344, issue.jan04 4, p.7622
DOI : 10.1136/bmj.d7622

URL : https://hal.archives-ouvertes.fr/inserm-00677226

A. Larue and L. Jarvik, Cognitive function and prediction of dementia in old age, Int J Ageing Hum Dev, vol.25, pp.79-89, 1987.

R. Mcdonald and N. White, A triple dissociation of memory systems: Hippocampus, amygdala, and dorsal striatum., Behavioral Neuroscience, vol.107, issue.1, pp.3-22, 1993.
DOI : 10.1037/0735-7044.107.1.3

M. Smith and B. Milner, The role of the right hippocampus in the recall of spatial location, Neuropsychologia, vol.19, issue.6, pp.781-93, 1981.
DOI : 10.1016/0028-3932(81)90090-7

E. Maguire, C. Frith, and N. Burgess, Knowing Where Things Are: Parahippocampal Involvement in Encoding Object Locations in Virtual Large-Scale Space, Journal of Cognitive Neuroscience, vol.11, issue.1, pp.61-76, 1998.
DOI : 10.1037/0735-7044.99.1.22

M. Laakso, M. Hallikainen, and T. Hanninen, Diagnosis of Alzheimer???s disease: MRI of the hippocampus vs delayed recall, Neuropsychologia, vol.38, issue.5, pp.579-84, 2000.
DOI : 10.1016/S0028-3932(99)00111-6

G. Chrousos, Stress and disorders of the stress system, Nature Reviews Endocrinology, vol.138, issue.7, pp.374-81, 2009.
DOI : 10.1038/nrendo.2009.106

R. Rosmond and P. Bjorntorp, The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke, Journal of Internal Medicine, vol.320, issue.2, pp.188-97, 2000.
DOI : 10.1046/j.1365-2796.1997.00235.x

I. Beluche, I. Chaudieu, and J. Norton, Persistence of abnormal cortisol levels in elderly persons after recovery from major depression, Journal of Psychiatric Research, vol.43, issue.8, pp.777-83, 2009.
DOI : 10.1016/j.jpsychires.2008.10.011

URL : https://hal.archives-ouvertes.fr/inserm-00360626

J. Csernansky, H. Dong, and A. Fagan, Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia, American Journal of Psychiatry, vol.163, issue.12
DOI : 10.1176/ajp.2006.163.12.2164

C. Franz, O. Brien, R. Hauger, and R. , Cross-sectional and 35-year longitudinal assessment of salivary cortisol and cognitive functioning: The Vietnam Era Twin Study of Aging, Psychoneuroendocrinology, vol.36, issue.7, pp.1040-52
DOI : 10.1016/j.psyneuen.2011.01.002

N. Sousa, J. Cerqueira, and O. Almeida, Corticosteroid receptors and neuroplasticity, Brain Research Reviews, vol.57, issue.2, pp.561-70, 2008.
DOI : 10.1016/j.brainresrev.2007.06.007

K. Green, L. Billings, and B. Roozendaal, Glucocorticoids Increase Amyloid-beta and Tau Pathology in a Mouse Model of Alzheimer's Disease, Journal of Neuroscience, vol.26, issue.35, pp.9047-56, 2006.
DOI : 10.1523/JNEUROSCI.2797-06.2006

C. Laske, E. Stransky, and A. Fritsche, Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/A?? 1???42 ratios in CSF in patients with mild Alzheimer???s disease dementia, European Archives of Psychiatry and Clinical Neuroscience, vol.12, issue.9, pp.80-85, 2009.
DOI : 10.1007/s00406-008-0838-3

F. Gil-bea, B. Aisa, and A. Solomon, HPA Axis Dysregulation Associated to Apolipoprotein E4 Genotype in Alzheimer's Disease, Journal of Alzheimer's Disease, vol.22, issue.3, pp.829-867
DOI : 10.3233/JAD-2010-100663

W. Kremen, O. Brien, R. Panizzon, and M. , Salivary cortisol and prefrontal cortical thickness in middle-aged men: A twin study, NeuroImage, vol.53, issue.3, pp.1093-102
DOI : 10.1016/j.neuroimage.2010.02.026

M. Henckens, Z. Pu, and E. Hermans, Dynamically changing effects of corticosteroids on human hippocampal and prefrontal processing, Human Brain Mapping, vol.135, issue.12
DOI : 10.1002/hbm.21409

M. Henckens, G. Van-wingen, and M. Joels, Time-Dependent Effects of Corticosteroids on Human Amygdala Processing, Journal of Neuroscience, vol.30, issue.38, pp.12725-12757
DOI : 10.1523/JNEUROSCI.3112-10.2010

S. Iliffe, L. Curry, and K. Kharicha, Developing a Dementia Research Registry: a descriptive case study from North Thames DeNDRoN and the EVIDEM programme, BMC Medical Research Methodology, vol.13, issue.2
DOI : 10.1097/00002093-199904000-00003

M. Parra, S. Abrahams, and K. Fabi, Short-term memory binding deficits in Alzheimer's disease, Brain, vol.132, issue.4, pp.1057-66, 2009.
DOI : 10.1093/brain/awp036